Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study

Peer Review reports

Original Submission
15 Feb 2021	Submitted	Original manuscript
26 Feb 2021	Author responded	Author comments - Yukinori Ozaki
Resubmission - Version 2
26 Feb 2021	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
19 Mar 2021	Reviewed	Reviewer Report - Hans-christian Kolberg
3 Dec 2021	Reviewed	Reviewer Report
8 Dec 2021	Author responded	Author comments - Yukinori Ozaki
Resubmission - Version 5
8 Dec 2021	Submitted	Manuscript version 5
Publishing
16 Dec 2021	Editorially accepted
4 Jan 2022	Article published	10.1186/s12885-021-09128-1

Back to article page